Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.

Autor: Taşçı EŞ; Department of Medical Oncology, Kanuni Sultan Süleyman Education and Research Hospital, Istanbul, Turkey., Kutlu Y; Department of Medical Oncology, Medipol University, Istanbul, Turkey., Ölmez ÖF; Department of Medical Oncology, Medipol University, Istanbul, Turkey., Mutlu AU; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Gündoğdu Y; Department of Internal Medicine, Acıbadem MAA University, Istanbul, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Şahin E; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Çabuk D; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Majidova N; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Uğurlu İ; Department of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey., Demirci A; Department of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey., Aydın D; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey., Çavdar E; Department of Medical Oncology, Namık Kemal University, Tekirdağ, Turkey., Bayram S; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Yıldırım N; Department of Medical Oncology, Fırat University Faculty of Medicine, Elazığ, Turkey., Karataş F; Department of Medical Oncology, Karabük University Faculty of Medicine, Karabük, Turkey., Eryılmaz MK; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Çağlayan D; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Menekşe S; Department of Medical Oncology, Manisa City Hospital, Manisa, Turkey., Kut E; Department of Medical Oncology, Manisa City Hospital, Manisa, Turkey., Arak H; Department of Medical Oncology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey., Keser M; Department of Medical Oncology, Tepecik Training and Research Hospital, Istanbul, Turkey., Sunar V; Department of Medical Oncology, Aydın Atatürk Public Hospital, Aydın, Turkey., Perkin P; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Şakalar T; Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Oyan B; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey., Sönmez Ö; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey., Özer L; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey., Yıldız İ; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey.

Publikováno v: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Mar; Vol. 25 (4), pp. 477-484. Date of Electronic Publication: 2024 Apr 03.

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Autor: Taşçı EŞ; Department of Medical Oncology, Saglık Bilimleri University, Kanuni Sultan Süleyman Research and Training Hospital, Istanbul, Turkey. esenocak@gmail.com., Oyan B; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Sönmez Ö; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Mutlu AU; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Atcı MM; Department of Medical Oncology, Haseki Education and Research Hospital, Istanbul, Turkey., Sakin A; Department of Medical Oncology, Medipol Bahçelievler Hospital, Istanbul, Turkey., Öner İ; Department of Medical Oncology, Konya City Hospital, Konya, Turkey., Çınkır HY; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey., Eryılmaz MK; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Çağlayan D; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Balçık OY; Department of Medical Oncology, Mardin Education and Research Hospital, Mardin, Turkey., Paksoy N; Department of Medical Oncology, Tekirdağ Dr. İsmail Fehmi Cumalıoğlu City Hospital, Tekirdağ, Turkey., Karabulut S; Department of Medical Oncology, Şişli Kolan Hospital, Istanbul, Turkey., Salim DK; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Bilir C; Department of Medical Oncology, Medical Park Hospital, Istanbul, Turkey., Özen M; Department of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey., Özçelik M; Department of Medical Oncology, University of Health Sciences Umraniye Education and Research Hospital, Istanbul, Turkey., Arıcan A; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Akagündüz B; Department of Medical Oncology, Binali Yıldırım University, Erzincan, Turkey., İnal A; Department of Medical Oncology, Mersin City Hospital, Mersin, Turkey., Aydın D; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey., Özer L; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Gülmez A; Department of Medical Oncology, Adana City Hospital, Adana, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Esen SA; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Algın E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Akbaş S; Department of Medical Oncology, Koç University Hospital, Istanbul, Turkey., İriağaç Y; Department of Medical Oncology, Namık Kemal University, Tekirdağ, Turkey., Şakalar T; Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Ünal Ç; Department of Medical Oncology, Bilim University, Istanbul, Turkey., Er Ö; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Seçmeler Ş; Department of Medical Oncology, Medical Park Bahçelievler Hospital, Istanbul, Turkey., Bozkurt M; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey.

Publikováno v: BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 16. Date of Electronic Publication: 2024 Jan 02.

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).

Autor: Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Sakin A; Department of Medical Oncology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey., Başoğlu T; Department of Medical Oncology, School of Medicine, Marmara University, İstanbul, Turkey., Özden E; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Çabuk D; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Doğan M; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Öksüzoğlu B; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Yıldırım HÇ; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Öner İ; Department of Medical Oncology, Konya Meram State Hospital, Konya, Turkey., Eryılmaz MK; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Dülgar Ö; Department of Medical Oncology, Göztepe Training and Research Hospital, İstanbul Medeniyet University, İstanbul, Turkey., Aydın D; Department of Medical Oncology, Derince Training and Research Hospital, Kocaeli, Turkey., Doğan N; Department of Medical Oncology, Prof. Dr. A. İlhan Özdemir Education and Research Hospital, Giresun University, Giresun, Turkey., Özen M; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Hacıbekiroğlu İ; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Özdemir N; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey., Gürler F; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey., Paksoy N; Department of Medical Oncology, Institute of Oncology, İstanbul University, İstanbul, Turkey., Karabulut S; Department of Medical Oncology, Institute of Oncology, İstanbul University, İstanbul, Turkey., Aksoy A; Department of Medical Oncology, Faculty of Medicine, Fırat University, Elazığ, Turkey., Hızal M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Kahraman S; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Şen E; Department of Medical Oncology, Çanakkale Mehmet Akif Ersoy State Hospital, Çanakkale, Turkey., Paydaş S; Department of Medical Oncology, Faculty of Medicine, Çukurova University, Adana, Turkey., Çılbır E; Department of Medical Oncology, Dışkapı Training and Research Hospital, Ankara, Turkey., Fırat F; Department of Medical Oncology, Faculty of Medicine, İnönü University, Malatya, Turkey., Akdeniz N; Department of Medical Oncology, Adıyaman Training and Research Hospital, Adıyaman, Turkey., Özçelik M; Department of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul, Turkey., Oyman A; Department of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul, Turkey., Baytemür NK; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey., Acar R; Department of Medical Oncology, Gülhane Education and Research Hospital, Ankara, Turkey., Almuradova E; Department of Medical Oncology, Faculty of Medicine, Ege University, İzmir, Turkey., Karabulut B; Department of Medical Oncology, Faculty of Medicine, Ege University, İzmir, Turkey., Şakalar T; Department of Medical Oncology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Arak H; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey., Değerli E; Department of Medical Oncology, Cerrahpaşa School of Medicine, İstanbul University, İstanbul, Turkey., Türker S; Department of Medical Oncology, Zonguldak Atatürk State Hospital, Zonguldak, Turkey., Alan Ö; Department of Medical Oncology, Tekirdağ State Hospital, Tekirdağ, Turkey., Er Ö; Department of Medical Oncology, Acıbadem Maslak Hospital, İstanbul, Turkey., Taşçı EŞ; Department of Medical Oncology, Acıbadem Maslak Hospital, İstanbul, Turkey., Demir N; Department of Medical Oncology, Faculty of Medicine, Osmangazi University, Eskişehir, Turkey., Çavdar E; Department of Medical Oncology, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Turkey., Turhal S; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Dede DŞ; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turke., Akıncı MB; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turke., Yalçın B; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turke., Yumuk F; Department of Medical Oncology, School of Medicine, Marmara University, İstanbul, Turkey., Yalçın Ş; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Şendur MAN; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turke.

Publikováno v: Turkish journal of medical sciences [Turk J Med Sci] 2022 Aug; Vol. 52 (4), pp. 1022-1032. Date of Electronic Publication: 2022 Aug 10.